Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 22, 2014 11:07 ET | Source: Swedish Orphan Biovitrum AB (publ)

Sobi opens North American operations

STOCKHOLM, Sweden, Sept. 22, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi) today formally opened the company's new North American office in Waltham, Massachusetts with a ribbon...
July 01, 2014 03:32 ET | Source: Swedish Orphan Biovitrum AB (publ)

Sobi awarded Company of the Year at the European Mediscience Awards 2014

Stockholm, Sweden, July 1, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi) has been awarded the Company of the Year Award at the European Mediscience Awards 2014. The Company of the...
June 05, 2014 02:08 ET | Source: Swedish Orphan Biovitrum AB (publ)

Sobi Establishes North American Office in Massachusetts

STOCKHOLM, Sweden, June 5, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi) today announced that the Company has decided to establish its North American operations in Waltham,...
May 08, 2014 12:35 ET | Source: Swedish Orphan Biovitrum AB (publ)

Swedish Orphan Biovitrum AB (publ): Resolutions from Sobi's AGM

Stockholm, Sweden, May 8, 2014 (GLOBE NEWSWIRE) -- The Swedish Orphan Biovitrum AB (publ) (Sobi) Annual General meeting (AGM) convened earlier today in Stockholm and voted in favour of the resolutions...
May 08, 2014 12:34 ET | Source: Swedish Orphan Biovitrum AB (publ)

Swedish Orphan Biovitrum AB (publ): Annette Clancy joins Sobi's Board of Directors

Stockholm, Sweden, May 8, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi) Annual General meeting (AGM) today elected Annette Clancy to Sobi's Board of Directors. Ms. Clancy has over...
April 03, 2014 02:09 ET | Source: Swedish Orphan Biovitrum AB (publ)

Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)

STOCKHOLM, Sweden, April 3, 2014 (GLOBE NEWSWIRE) -- The shareholders in Swedish Orphan Biovitrum AB (publ), Reg. No. 556038-9321, are hereby summoned to the annual general meeting (the "Meeting"), to...
April 01, 2014 02:07 ET | Source: Swedish Orphan Biovitrum AB (publ)

Sobi assumes direct responsibility for Orfadin(r) (nitisinone) in US and Canada and introduces Orfadin4U(TM)

STOCKHOLM, Sweden, April 1, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi) today assumed direct responsibility for the distribution of its proprietary product Orfadin in the United...
March 31, 2014 02:05 ET | Source: Swedish Orphan Biovitrum AB (publ)

Sobi: US FDA approves Alprolix(TM)

STOCKHOLM, Sweden, March 31, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB's (publ) (Sobi) partner Biogen Idec have announced that the US Food and Drug Administration (FDA) has approved...
March 26, 2014 08:08 ET | Source: Swedish Orphan Biovitrum AB (publ)

Sobi: Kiobrina pivotal phase 3 study did not meet primary endpoint

STOCKHOLM, March 26, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi) today announced topline data from the company's pivotal phase 3 study of its enzyme therapy Kiobrina (rhBSSL -...
March 21, 2014 08:08 ET | Source: Swedish Orphan Biovitrum AB (publ)

Health Canada approves Alprolix(TM)

Stockholm, Sweden, March 21, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB's (pupl) (Sobi) partner Biogen Idec today announced that Health Canada has approved Alprolix(TM) (Coagulation Factor...